Generate Biomedicines, Inc. Common Stock (GENB) — Net Asset Momentum
Generate Biomedicines, Inc. Common Stock (GENB) recorded a net asset momentum of -43.2% as of December 2025, with net assets of $-623.20 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Generate Biomedicines, Inc. Common Stock fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Generate Biomedicines, Inc. Common Stock Net Asset Momentum (2024–2025)
This chart tracks Generate Biomedicines, Inc. Common Stock's year-over-year net asset growth across 2 annual reporting periods from 2024 to 2025. The most recent momentum reading is -43.2%, with net assets of $-623.20 Million USD as of December 2025. Read Generate Biomedicines, Inc. Common Stock debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Generate Biomedicines, Inc. Common Stock (2024–2025)
The table below shows the complete annual net asset history for Generate Biomedicines, Inc. Common Stock from 2024 to 2025, covering 2 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see GENB stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-623.20 Million | $330.18 Million | $953.38 Million | ▼ -43.2% |
| 2024 | $-435.09 Million | $518.26 Million | $953.35 Million | — |